VolitionRx Limited
VNRX
$0.566
-$0.024-4.07%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.29M | 976.50K | 797.00K | 775.30K | 651.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.29M | 976.50K | 797.00K | 775.30K | 651.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.29M | 976.50K | 797.00K | 775.30K | 651.00K |
| SG&A Expenses | 14.91M | 16.21M | 16.85M | 17.21M | 16.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.27M | 33.75M | 36.12M | 36.76M | 35.91M |
| Operating Income | -29.98M | -32.77M | -35.33M | -35.99M | -35.26M |
| Income Before Tax | -30.20M | -32.79M | -35.28M | -35.68M | -34.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.20 | -32.79 | -35.28 | -35.68 | -34.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 327.70K | 363.60K | 369.30K | 358.10K | 350.70K |
| Net Income | -29.87M | -32.42M | -34.91M | -35.32M | -33.86M |
| EBIT | -29.98M | -32.77M | -35.33M | -35.99M | -35.26M |
| EBITDA | -28.87M | -31.64M | -34.18M | -34.84M | -34.15M |
| EPS Basic | -0.36 | -0.40 | -0.46 | -0.50 | -0.52 |
| Normalized Basic EPS | -0.22 | -0.25 | -0.29 | -0.31 | -0.32 |
| EPS Diluted | -0.36 | -0.40 | -0.46 | -0.50 | -0.52 |
| Normalized Diluted EPS | -0.22 | -0.25 | -0.29 | -0.31 | -0.32 |
| Average Basic Shares Outstanding | 331.97M | 322.26M | 306.47M | 284.69M | 262.83M |
| Average Diluted Shares Outstanding | 331.97M | 322.26M | 306.47M | 284.69M | 262.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
